This Article Full Text Full Text (PDF) All Versions of this Article: 117/5/678    most recent CIRCULATIONAHA.107.707349v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Badellino, K. O. Articles by Rader, D. J. PubMed PubMed Citation Articles by Badellino, K. O. Articles by Rader, D. J. Pubmed/NCBI databases Substance via MeSH Related Collections Obesity Lipid and lipoprotein metabolism Risk Factors Other arteriosclerosis Related Article

(Circulation. 2008;117:678-685.)
© 2008 American Heart Association, Inc.

Vascular Medicine

Endothelial Lipase Is Increased In Vivo by Inflammation in Humans

Karen O. Badellino, PhD, RN; Megan L. Wolfe, BS; Muredach P. Reilly, MB; Daniel J. Rader, MD

From the School of Nursing (K.O.B.), Institute of Translational Medicine and Therapeutics (K.O.B., M.L.W., M.P.R., D.J.R.), School of Medicine (M.P.R., D.J.R.), and Cardiovascular Institute (M.P.R.), University of Pennsylvania, Philadelphia.

Correspondence to Karen O. Badellino, PhD, RN, Assistant Professor of Nursing, Investigator, Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, PA 19104. E-mail kbadelli{at}nursing.upenn.edu

Received April 5, 2007; accepted December 14, 2007.

Background— Endothelial lipase (EL) is a plasma lipase that we previously reported to be significantly correlated with all features of the metabolic syndrome in humans, including directly with measures of adiposity and inversely with high-density lipoprotein cholesterol levels. We hypothesized that inflammation associated with obesity results in upregulation of EL. We determined the relationship between inflammatory markers and EL levels in a cohort of healthy persons recruited on the basis of family history of coronary disease. Furthermore, we directly tested the hypothesis that plasma EL concentrations would increase with induction of an inflammatory state by low-dose endotoxin in humans.

Methods and Results— High-sensitivity C-reactive protein, interleukin 6, soluble tumor necrosis factor receptor II, soluble intercellular adhesion molecule 1, leptin, and adiponectin were measured in plasma of 858 subjects. Significant direct correlations (P<0.001 for all) were found between EL concentrations and high-sensitivity C-reactive protein (r=0.28), interleukin-6 (r=0.22), soluble tumor necrosis factor receptor II (r=0.22), soluble intercellular adhesion molecule 1 (r=0.24), and leptin (r=0.20). An inverse correlation was present with adiponectin (r=–0.15, P<0.001). Adiponectin inhibited the tumor necrosis factor-–stimulated EL secretion from cultured human coronary endothelial cells in a dose-dependent manner. Experimental low-dose endotoxemia in 20 subjects resulted in a 2.5-fold increase in EL concentrations 12 to 16 hours after injection, which correlated temporally with decreases in both total and high-density lipoprotein phospholipid.

Conclusions— In humans, plasma inflammatory markers are directly correlated with plasma EL concentrations, and experimental endotoxemia significantly increases plasma EL concentrations, proving that EL is upregulated by inflammation in humans. This mechanism may partially explain the low high-density lipoprotein cholesterol levels seen in obesity and metabolic syndrome.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2008 117: 589-591. [Full Text]

This article has been cited by other articles:

				R. J. Brown and D. J. Rader When HDL Gets Fat ... Circ. Res., July 18, 2008; 103(2): 131 - 132. [Full Text] [PDF]

				C. Xiao, T. Watanabe, Y. Zhang, B. Trigatti, L. Szeto, P. W. Connelly, S. Marcovina, T. Vaisar, J. W. Heinecke, and G. F. Lewis Enhanced Cellular Uptake of Remnant High-Density Lipoprotein Particles: A Mechanism for High-Density Lipoprotein Lowering in Insulin Resistance and Hypertriglyceridemia Circ. Res., July 18, 2008; 103(2): 159 - 166. [Abstract] [Full Text] [PDF]